Article Information
vol. 49 no. 2
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 1, 2016
- Accepted November 3, 2016
- Published online February 8, 2017.
Copyright & Usage
Copyright ©ERS 2017
Author Information
- Chih-Hsi Scott Kuo1,2,3,
- Stelios Pavlidis4,
- Matthew Loza4,
- Fred Baribaud4,
- Anthony Rowe4,
- Iaonnis Pandis3,
- Ana Sousa5,
- Julie Corfield6,7,
- Ratko Djukanovic8,
- Rene Lutter9,
- Peter J. Sterk9,
- Charles Auffray8,10,
- Yike Guo3,
- Ian M. Adcock1,2,11 and
- Kian Fan Chung1,2,11⇑
- on behalf of the U-BIOPRED Study Group12
- 1Airways Disease, National Heart and Lung Institute, Imperial College London, London, UK
- 2Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK
- 3Dept of Computing and Data Science Institute, Imperial College London, London, UK
- 4Janssen R&D, High Wycombe, UK
- 5Respiratory Therapeutic Unit, GSK, Stockley Park, UK
- 6AstraZeneca R&D, Mölndal, Sweden
- 7Areteva R&D, Nottingham, UK
- 8Faculty of Medicine, Southampton University, Southampton, UK
- 9Faculty of Medicine, University of Amsterdam, Amsterdam, The Netherlands
- 10European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, France
- 11These authors contributed equally to this work
- 12A full list of the U-BIOPRED Consortium project team member and their affiliations can be found in the Acknowledgements section
- K.F. Chung, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. E-mail: f.chung{at}imperial.ac.uk
Funding
European Union and European Federation of Pharmaceutical Industries and Associations
IMI JU funded project (no. 115010)